Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia B, Congenital”

323 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 323 results

Not applicableWithdrawnNCT06634836
What this trial is testing

Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B

Who this might be right for
Hemophilia AHemophilia B
Pfizer
Not applicableStudy completedNCT01959555
What this trial is testing

Project to Update the Study of Congenital Haemophilia in Spain

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 1,157
Not applicableStudy completedNCT02300519
What this trial is testing

Thrombin Generation Numerical Models Validation in Haemophilic Case

Who this might be right for
Haemophilia BHaemophilia A
Centre Hospitalier Universitaire de Saint Etienne 40
Large-scale testing (Phase 3)Study completedNCT03855280
What this trial is testing

Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B

Who this might be right for
Hemophilia B
Medexus Pharma, Inc. 21
Post-approval studies (Phase 4)Study completedNCT00108797
What this trial is testing

Trial of NovoSeven® in Haemophilia - Joint Bleeds

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 42
Large-scale testing (Phase 3)Study completedNCT02250560
What this trial is testing

Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.

Who this might be right for
Haemophilia B
Bio Products Laboratory
Not applicableStudy completedNCT02241694
What this trial is testing

To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+3 more
Novo Nordisk A/S 200
Testing effectiveness (Phase 2)Study completedNCT03370172
What this trial is testing

BAX 888 in Male Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 4
Post-approval studies (Phase 4)WithdrawnNCT00168051
What this trial is testing

Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Large-scale testing (Phase 3)Study completedNCT00037557
What this trial is testing

Study Evaluating rFIX; BeneFIX in Severe Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 20
Not applicableStudy completedNCT02740413
What this trial is testing

Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study

Who this might be right for
Hemophilia AHemophilia B
Pfizer 86
Large-scale testing (Phase 3)Study completedNCT01507896
What this trial is testing

BAX 326 Surgery Study in Hemophilia B Patients

Who this might be right for
Hemophilia B
Baxalta now part of Shire 30
Not applicableStudy completedNCT00927992
What this trial is testing

Study Evaluating Liver Transplantation in Haemophilia Patients in Spain

Who this might be right for
HemophiliaHemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 11
Early research (Phase 1)Study completedNCT00716716
What this trial is testing

Phase I/IIa Study of FIXFc in Hemophilia B Patients

Who this might be right for
Hemophilia B
Bioverativ Therapeutics Inc. 10
Testing effectiveness (Phase 2)Ended earlyNCT05164471
What this trial is testing

Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B

Who this might be right for
Hemophilia B
Spur Therapeutics 6
Early research (Phase 1)Study completedNCT01379300
What this trial is testing

Investigate Biomarkers After Single Doses of Anticoagulants in Healthy Young Male and Healthy Elderly Participants (MK-0000-216 AM1)

Who this might be right for
Thrombosis
Merck Sharp & Dohme LLC 42
Early research (Phase 1)Study completedNCT01563471
What this trial is testing

Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors+1 more
Novo Nordisk A/S 39
Early research (Phase 1)Study completedNCT02213250
What this trial is testing

An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 12
Large-scale testing (Phase 3)Study completedNCT01425723
What this trial is testing

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

Who this might be right for
Severe Hemophilia B
Bioverativ Therapeutics Inc. 120
Not applicableStudy completedNCT02796222
What this trial is testing

Factor Product Utilization and Health Outcomes in Patients With Hemophilia

Who this might be right for
Hemophilia A, CongenitalHemophilia B, Congenital
University of British Columbia 61
Load More Results